Edgewise Therapeutics's total assets for Q1 2026 were $518.52M, a decrease of -6.17% from the previous quarter. EWTX total liabilities were $25.32M for the fiscal quarter, a -16.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.